Home
STRO
STRO News

Latest Sutro Biopharma Inc. (STRO) News on January 19, 2025

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

12 days ago

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale

GlobeNewswire

12 days ago

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale

Sutro Biopharma, Inc.'s (NASDAQ:STRO) latest 24% decline adds to one-year losses, institutional investors may consider drastic measures

Simply Wall St.

a month ago

Sutro Biopharma, Inc.'s (NASDAQ:STRO) latest 24% decline adds to one-year losses, institutional investors may consider drastic measures

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer

GlobeNewswire

a month ago

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer

Sutro Biopharma (STRO) Upgraded to Buy: Here's What You Should Know

Zacks

2 months ago

Sutro Biopharma (STRO) Upgraded to Buy: Here's What You Should Know

Sutro Biopharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

Sutro Biopharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates

Zacks

2 months ago

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

2 months ago

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference

GlobeNewswire

2 months ago

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference

Sutro Biopharma begins trial of acute myeloid leukaemia treatment in children

Clinical Trials Arena

2 months ago

Sutro Biopharma begins trial of acute myeloid leukaemia treatment in children

MT Newswires

3 months ago

Sutro Biopharma Opens Enrollment for Luveltamab Tazevibulin Trial

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

GlobeNewswire

3 months ago

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

Sutro Biopharma (NASDAQ:STRO) shareholders have endured a 80% loss from investing in the stock three years ago

Simply Wall St.

3 months ago

Sutro Biopharma (NASDAQ:STRO) shareholders have endured a 80% loss from investing in the stock three years ago

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum

GlobeNewswire

3 months ago

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum

Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024

GlobeNewswire

4 months ago

Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024

Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024

GlobeNewswire

4 months ago

Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024

Sutro Biopharma (STRO) Rises 9% in the Past Week: Here's Why

Zacks

5 months ago

Sutro Biopharma (STRO) Rises 9% in the Past Week: Here's Why

Sutro Biopharma commences Phase II trial of luvelta for lung cancer

Clinical Trials Arena

5 months ago

Sutro Biopharma commences Phase II trial of luvelta for lung cancer

MT Newswires

5 months ago

Sutro Biopharma Initiates Phase 2 Trial of Luvelta in Non-Small Cell Lung Cancer

Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer

GlobeNewswire

5 months ago

Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer

MT Newswires

5 months ago

Truist Securities Adjusts Price Target on Sutro Biopharma to $15 From $18, Maintains Buy Rating

Companies Like Sutro Biopharma (NASDAQ:STRO) Are In A Position To Invest In Growth

Simply Wall St.

5 months ago

Companies Like Sutro Biopharma (NASDAQ:STRO) Are In A Position To Invest In Growth

Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates

Zacks

5 months ago

Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates

Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones

GlobeNewswire

5 months ago

Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones

Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer

GlobeNewswire

6 months ago

Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

7 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

7 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

7 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

7 months ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

7 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

7 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

7 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

7 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Shareholders Will Likely Find Sutro Biopharma, Inc.'s (NASDAQ:STRO) CEO Compensation Acceptable

Simply Wall St.

8 months ago

Shareholders Will Likely Find Sutro Biopharma, Inc.'s (NASDAQ:STRO) CEO Compensation Acceptable

Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks

TipRanks

8 months ago

Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks

MT Newswires

8 months ago

Sutro Biopharma Q1 Loss Widens, Revenue Rises

Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones

GlobeNewswire

8 months ago

Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones

Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for

Zacks

8 months ago

Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for

The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable

Simply Wall St.

8 months ago

The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable

MT Newswires

8 months ago

BofA Securities Starts Sutro Biopharma With Buy Rating

AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?

Zacks

9 months ago

AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?

Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial

GlobeNewswire

9 months ago

Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial

Sutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts Substantially

Simply Wall St.

10 months ago

Sutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts Substantially

Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering

GlobeNewswire

10 months ago

Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering

Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances

GuruFocus.com

10 months ago

Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances

Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates

Zacks

10 months ago

Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates

Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones

GlobeNewswire

10 months ago

Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones

Here's Why Sutro Biopharma (STRO) Is a Great 'Buy the Bottom' Stock Now

Zacks

10 months ago

Here's Why Sutro Biopharma (STRO) Is a Great 'Buy the Bottom' Stock Now

Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?

Zacks

a year ago

Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?

Sutro Biopharma to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Sutro Biopharma to Participate in Upcoming Investor Conferences

Gilat Awarded Multimillion-Dollar Defense Satellite Connectivity Project

GlobeNewswire

a year ago

Gilat Awarded Multimillion-Dollar Defense Satellite Connectivity Project

Cipher Mining Announces Date of Fourth Quarter and Full Year 2023 Business Update Conference Call

GlobeNewswire

a year ago

Cipher Mining Announces Date of Fourth Quarter and Full Year 2023 Business Update Conference Call

AM Best Withdraws Credit Ratings of Accelerant Re Ltd.

Business Wire

a year ago

AM Best Withdraws Credit Ratings of Accelerant Re Ltd.

Apparel Retailer Stocks Q3 Recap: Benchmarking Victoria's Secret (NYSE:VSCO)

StockStory

a year ago

Apparel Retailer Stocks Q3 Recap: Benchmarking Victoria's Secret (NYSE:VSCO)

European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques

GlobeNewswire

a year ago

European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques

IBEX Limited to Announce Second Quarter 2024 Financial Results on February 8, 2024

GlobeNewswire

a year ago

IBEX Limited to Announce Second Quarter 2024 Financial Results on February 8, 2024

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

GlobeNewswire

a year ago

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Kicking Around Preliminary Earnings Trends in the Consumer Space

GuruFocus.com

a year ago

Kicking Around Preliminary Earnings Trends in the Consumer Space

LINKBANCORP, Inc. (LNKB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

a year ago

LINKBANCORP, Inc. (LNKB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Reuters

a year ago

IN CASE YOU MISSED IT–Schedule of Reuters features from this week

Silvercorp Receives TSX Conditional Approval in Connection with OreCorp Offer

CNW Group

a year ago

Silvercorp Receives TSX Conditional Approval in Connection with OreCorp Offer

Nestlé Joins Growing List of National and Multinational Companies Operating at the Tejon Ranch Commerce Center

GlobeNewswire

a year ago

Nestlé Joins Growing List of National and Multinational Companies Operating at the Tejon Ranch Commerce Center

Turtle Beach (HEAR) Soars 11.9%: Is Further Upside Left in the Stock?

Zacks

a year ago

Turtle Beach (HEAR) Soars 11.9%: Is Further Upside Left in the Stock?

Everlane CEO jumps to Designer Brands

Retail Dive

a year ago

Everlane CEO jumps to Designer Brands

Unpacking Q3 Earnings: Tilly's (NYSE:TLYS) In The Context Of Other Apparel Retailer Stocks

StockStory

a year ago

Unpacking Q3 Earnings: Tilly's (NYSE:TLYS) In The Context Of Other Apparel Retailer Stocks

Is GrafTech International Ltd. (NYSE:EAF) Potentially Undervalued?

Simply Wall St.

a year ago

Is GrafTech International Ltd. (NYSE:EAF) Potentially Undervalued?

With 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investors

Simply Wall St.

a year ago

With 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investors

Caesars Entertainment (CZR) Moves 5.3% Higher: Will This Strength Last?

Zacks

a year ago

Caesars Entertainment (CZR) Moves 5.3% Higher: Will This Strength Last?

Should You Buy Small Cap Stocks Right Now?

Zacks

a year ago

Should You Buy Small Cap Stocks Right Now?

Newtek Small Business Loan Trust Securitizations Ratings Upgraded by S&P Global Ratings

GlobeNewswire

a year ago

Newtek Small Business Loan Trust Securitizations Ratings Upgraded by S&P Global Ratings

The past three years for NewtekOne (NASDAQ:NEWT) investors has not been profitable

Simply Wall St.

a year ago

The past three years for NewtekOne (NASDAQ:NEWT) investors has not been profitable

Yext to Present at Upcoming Investor Conferences

Business Wire

a year ago

Yext to Present at Upcoming Investor Conferences

Gilat Awarded $17 Million by Pronatel for Expansion of Regional Telecommunications Project in Peru

GlobeNewswire

a year ago

Gilat Awarded $17 Million by Pronatel for Expansion of Regional Telecommunications Project in Peru

Mercantile Bank (MBWM) Q4 Earnings and Revenues Top Estimates

Zacks

a year ago

Mercantile Bank (MBWM) Q4 Earnings and Revenues Top Estimates

Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently

Insider Monkey

a year ago

Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently

Picks and Shovels: 3 Stealth AI Stocks Flying Under Wall Street’s Radar

InvestorPlace

a year ago

Picks and Shovels: 3 Stealth AI Stocks Flying Under Wall Street’s Radar

These Stocks Moved the Most Today: Juniper, Intuitive Surgical, Meta, Aehr Test Systems, WD-40, Home Depot, Lennar, and More

Barrons.com

a year ago

These Stocks Moved the Most Today: Juniper, Intuitive Surgical, Meta, Aehr Test Systems, WD-40, Home Depot, Lennar, and More

PALISADES ANNOUNCES NEW FOUND INTERCEPTS AT HONEYPOT ZONE AT QUEENSWAY PROJECT

CNW Group

a year ago

PALISADES ANNOUNCES NEW FOUND INTERCEPTS AT HONEYPOT ZONE AT QUEENSWAY PROJECT

Business Wire

a year ago

Allego to Present at the 26th Annual Needham Growth Conference

Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks

StockStory

a year ago

Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks

Applebee’s® Brings Back All You Can Eat Boneless Wings, Riblets, and Double Crunch Shrimp to Kick Off New Year

Business Wire

a year ago

Applebee’s® Brings Back All You Can Eat Boneless Wings, Riblets, and Double Crunch Shrimp to Kick Off New Year

Business Wire

a year ago

Xponential Fitness, Inc. Provides 2023 Operating Highlights

Returns On Capital Are Showing Encouraging Signs At Xponential Fitness (NYSE:XPOF)

Simply Wall St.

a year ago

Returns On Capital Are Showing Encouraging Signs At Xponential Fitness (NYSE:XPOF)

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC

GlobeNewswire

a year ago

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC

Xerox layoffs, Xponential Fitness downgrade: Trending Stocks

Yahoo Finance Video

a year ago

Xerox layoffs, Xponential Fitness downgrade: Trending Stocks

Red River Bancshares (NASDAQ:RRBI) Ticks All The Boxes When It Comes To Earnings Growth

Simply Wall St.

a year ago

Red River Bancshares (NASDAQ:RRBI) Ticks All The Boxes When It Comes To Earnings Growth

2 Highly Ranked Stocks to Buy for Growth & Value at Year's End

Zacks

a year ago

2 Highly Ranked Stocks to Buy for Growth & Value at Year's End

Zacks.com featured highlights include REX American Resources, Consolidated Water and Beacon Roofing Supply

Zacks

a year ago

Zacks.com featured highlights include REX American Resources, Consolidated Water and Beacon Roofing Supply

Betterware de MéxicoP.I. de (NASDAQ:BWMX) shareholders have earned a 140% return over the last year

Simply Wall St.

a year ago

Betterware de MéxicoP.I. de (NASDAQ:BWMX) shareholders have earned a 140% return over the last year

Amerant Bancorp Inc. to Announce Fourth Quarter 2023 Financial Results and Host Conference Call

Business Wire

a year ago

Amerant Bancorp Inc. to Announce Fourth Quarter 2023 Financial Results and Host Conference Call

Willis Lease Finance Corp EVP, CFO Scott Flaherty Sells 2,638 Shares

GuruFocus.com

a year ago

Willis Lease Finance Corp EVP, CFO Scott Flaherty Sells 2,638 Shares

PETQ or ABT: Which Is the Better Value Stock Right Now?

Zacks

a year ago

PETQ or ABT: Which Is the Better Value Stock Right Now?

Clear Channel Outdoor, Terrible Herbst Score Touchdown-Worthy Ad Exposure for Brands for the "Big Game" and Beyond

PR Newswire

a year ago

Clear Channel Outdoor, Terrible Herbst Score Touchdown-Worthy Ad Exposure for Brands for the "Big Game" and Beyond

Business Wire

a year ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts

GlobeNewswire

a year ago

23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts

3 Top-Ranked Small-Caps with Big Growth

Zacks

a year ago

3 Top-Ranked Small-Caps with Big Growth

Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Boosted 48% But Its Business Prospects Need A Lift Too

Simply Wall St.

a year ago

Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Boosted 48% But Its Business Prospects Need A Lift Too

Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024

GlobeNewswire

a year ago

Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024

Want $200 in Monthly Dividend Income in 2024? Invest $27,000 in This Ultra-High-Yield Trio

Motley Fool

a year ago

Want $200 in Monthly Dividend Income in 2024? Invest $27,000 in This Ultra-High-Yield Trio

Share on Social Networks: